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Abstract 52 
Birt-Hogg-Dubé (BHD) syndrome is a rare autosomal dominant condition caused by mutations in the 53 
FLCN gene and characterised by benign hair follicle tumours, pneumothorax and renal cancer. Folliculin 54 
(FLCN), the protein product of the FLCN gene, is a poorly characterised tumour suppressor protein, 55 
currently linked to multiple cellular pathways. Autophagy maintains cellular homeostasis by removing 56 
damaged organelles and macromolecules. Although the autophagy kinase, ULK1, is known to drive 57 
autophagy, the mechanisms are not fully elucidated and few ULK1 substrates have been identified to 58 
date. Here, we identify that loss of FLCN moderately impairs basal autophagic flux, while re-expression 59 
of FLCN rescues autophagy. We reveal that FLCN is a new substrate of ULK1 and elucidate three novel 60 
ULK1-mediated phosphorylation sites (Ser406, Ser537 and Ser542) within FLCN. In addition to ULK1-61 
mediated phosphorylation of FLCN, our findings demonstrate that FLCN interacts with a second integral 62 
component of the autophagy machinery, GABARAP. The FLCN-GABARAP association is modulated by 63 
the presence of either FNIP1 or FNIP2. This FLCN-GABARAP interaction is further regulated by ULK1, 64 
through ULK1 phosphorylation of FLCN. As observed by elevation of GABARAP, SQSTM1 and LC3 in 65 
chromophobe and clear cell tumours from a BHD patient, we uncover that autophagy is impaired in 66 
BHD-associated renal tumours.  Consequently, this work reveals a novel facet of autophagy regulation by 67 
ULK1 and substantially contributes to our understanding of FLCN function by linking it directly to 68 
autophagy through GABARAP and ULK1.  69 
 70 
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Introduction 78 
 79 
Macroautophagy (hereafter referred to as autophagy) is an evolutionarily conserved process where 80 
intracellular lipid and protein components are broken down to replenish cellular energy and amino acid 81 
supplies. Autophagy also removes protein aggregates, redundant macromolecules and dysfunctional 82 
organelles that, if not efficiently recycled, contribute to cell stress and consequently disease.
1
 For 83 
example, autophagy plays both pro- and anti-oncogenic roles in cancer development (for a review see ref. 84 
1), while defects result in age-related cardiomyopathy
2
 and can lead to marked neurodegeneration.
3,4
 85 
Autophagy involves sequestering cytoplasmic material in double-membraned vesicles known as 86 
autophagosomes, which subsequently fuse with lysosomes to form autolysosomes. Once fusion occurs, 87 
lysosomal hydrolases degrade sequestered material allowing permeases to transport amino acids and 88 
lipids into the cytoplasm for use in either biosynthesis or the generation of energy (for a review see ref. 89 
5).  90 
 91 
Yeast screens uncovered over 30 autophagy-related (ATG) genes,
6
 many of which are recruited to the 92 
phagophore assembly site, a pre-autophagosomal membrane structure. ATG8 is conjugated to 93 
phosphatidylethanolamine (PE) and selectively incorporated into autophagosomes, making it a commonly 94 
used autophagy marker. Mammals have two ATG8 subfamilies, the microtubule-associated protein 1 light 95 
chain 3 (MAP1LC3, commonly called LC3) subgroup and the -aminobutyric acid receptor-associated 96 
protein (GABARAP)/Golgi-associated ATPase enhancer of 16 kDa (GATE-16) subfamily. Both 97 
mammalian ATG8 subfamilies are modified by PE conjugation, localise to autophagosomes
7
 and are 98 
essential for autophagy. Current evidence indicates that LC3 and GABARAP act at different stages of 99 
autophagosome formation.
8
 100 
 101 
The Unc-51 like kinase (ULK1) (the mammalian equivalent of Atg1) acts at the most upstream step of 102 
autophagy.
9
 ULK1 is a serine/threonine kinase that functions within a complex containing ATG13, 103 
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FIP200 and ATG101 to drive autophagosome formation.
10-13
 This kinase complex is positively regulated 104 
by many internal ULK1-mediated phosphorylation events, including ULK1 autophosphorylation.
10-12, 14
 In 105 
addition, when energy and nutrients are plentiful, the mechanistic target of rapamycin complex 1 106 
(mTORC1) promotes cell growth in part by inhibiting autophagy via phosphorylation of ULK1.
10,11 107 
Conversely, during energy and nutrient stress when cell growth is not feasible, AMP-dependent protein 108 
kinase (AMPK) interacts with and phosphorylates ULK1 to enhance autophagy.
15-18
 Downstream ULK1 109 
substrates have remained largely elusive. AMBRA1 was the first ULK1 substrate identified that is 110 
integral to the autophagy machinery
19
 but is not a component of the ULK1-ATG13-FIP200 complex. 111 
More recently, ULK1 phosphorylation of ATG9 has been identified as an important step during 112 
expansion of the isolation membrane.
20
 ULK1 is known to indirectly impact autophagy via 113 
phosphorylation of both AMPK
 21
 and Raptor within mTORC1.
22,23
  114 
 115 
Mutations in FLCN are responsible for Birt-Hogg-Dubé (BHD) syndrome (MIM #135150), characterised 116 
by benign hair follicle tumours, pneumothorax, cysts and renal cancer.
24
 BHD is a ciliopathy and FLCN is 117 
localised at primary cilia.
25
 Interestingly, a compromised ability to activate autophagy has been 118 
hypothesised to underlie some ciliopathies,
26
 raising the possibility that autophagy may be altered in BHD 119 
syndrome. In support of this autophagy connection, FLCN was recently shown to localise to lysosomes 120 
and modulate nutrient sensing through the Rag small G proteins.
27-29
 Given these findings, we wanted to 121 
ascertain whether autophagy is compromised in BHD syndrome. Our study uncovers a link between 122 
autophagy and BHD syndrome, revealing that FLCN is an important component of the autophagy 123 
machinery and is a downstream substrate of ULK1. 124 
 125 
 126 
 127 
 128 
 129 
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Results 130 
Loss of FLCN affects SQSTM1 expression - Sequestome-1 (SQSTM1, also known as p62) is an 131 
established marker of autophagy, which associates with autophagosomes and is degraded during 132 
autophagy.
30
 Of interest, SQSTM1 is often amplified in renal cell carcinoma.
31
 Given that BHD syndrome 133 
predisposes patients to renal cell carcinoma, we analysed whether FLCN loss could enhance SQSTM1 134 
protein levels. Previously, it was observed that tumour initiation via cystogenesis occurred within Flcn +/- 135 
mice upon loss of Flcn in renal proximal tubule cells.
32
 Therefore, we utilised human renal proximal 136 
tubule (HK2) cells with stable FLCN knockdown for our studies. We observed higher endogenous 137 
SQSTM1 protein expression in FLCN-deficient cells compared to control cells, which was more 138 
pronounced under normal growth conditions (Fig. 1A), implying FLCN may play a role in basal 139 
autophagy, but may be dispensable for acute starvation-induced autophagy. We also observed a similar 140 
pattern in Flcn
-/-
 mouse embryonic fibroblasts (MEFs) (Fig. S1A). We then re-expressed FLCN in FLCN-141 
deficient HK2 cells under normal growth conditions and co-expressed HA-SQSTM1 to specifically 142 
measure autophagy in the transfected cells. As indicated by reduced SQSTM1, re-expression of FLCN 143 
restored a higher level of basal autophagy (Fig. 1B). Immunohistochemistry revealed elevated SQSTM1 144 
protein levels in a BHD patient renal tumour (with a c.499C>T mutation encoding a truncated FLCN 145 
mutant, pGln167X) when compared to unaffected tissue (Fig. 1C). Collectively, this data reveals that the 146 
protein expression of SQSTM1 is negatively regulated by FLCN. 147 
 148 
FLCN-deficient cells exhibit impaired autophagy – We wanted to examine whether this elevation of 149 
SQSTM1 protein might be due to autophagy defects in the FLCN-deficient cells.  We assessed autophagic 150 
flux using a vector expressing tandem red and green fluorescent protein-tagged LC3 (RFP-GFP-LC3), 151 
which works on the principle that the GFP signal is less stable in the acidic environment of the lysosome 152 
than the RFP signal.
33
 Of the cells displaying multiple puncta under normal growth conditions, we 153 
detected proportionally fewer red puncta in the FLCN knockdown HK2 cells (Fig. 2A-B), indicating 154 
impaired maturation of autophagosomes (reduced fusion of autophagosomes with lysosomes), and 155 
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therefore reduced autophagic flux. This fits with our finding of SQSTM1 accumulation due to lack of 156 
degradation in lysosomes. Interestingly, in both HK2 cells (Fig. 2C) and HEK293 cells (Fig. 2D) FLCN 157 
knockdown causes a reduction in LC3B-II conversion following chloroquine treatment. As perturbation 158 
of autophagosome maturation would be expected to allow an accumulation of LC3B-II, this suggests that 159 
autophagosome synthesis may also be modestly impaired in FLCN-deficient cells. Analysis of another 160 
mammalian ATG8 orthologue, GABARAP, which has a potential role in regulating the sealing process 161 
needed for autophagosome maturation,
8
 revealed enhanced endogenous GABARAP expression in both 162 
FLCN-deficient HK2 and HEK293 cells (Fig. 2C-D). This elevation of GABARAP protein was not due to 163 
enhanced GABARAP gene expression, as mRNA levels were comparable between the cell lines (Fig. 164 
S1B).  Overall, this data indicates an impaired autophagy pathway operates in the absence of FLCN, 165 
along with altered GABARAP processing. 166 
 167 
FLCN interacts with GABARAP in the presence of FNIP1 and 2 - The FLCN binding partner, FNIP1, was 168 
recently shown to interact with GABARAP.
34
 Combined with our finding of enhanced GABARAP levels 169 
in FLCN-deficient cells, we wished to explore this connection further. Unbiased GABARAP interaction 170 
mass spectrometry was performed, and we identified eight high-confidence interacting proteins (Fig. 3A), 171 
including both FNIP1 and FLCN (FLCN peptide identification shown in Fig. S2A). We confirmed the 172 
FLCN-GABARAP interaction using an in vitro binding assay and could detect endogenous FLCN 173 
interaction with bacterially generated recombinant GABARAP protein (Fig. 3B). FLCN interacted more 174 
strongly with GABARAP than LC3B, a member of the other ATG8 subfamily (Fig. 3C), suggesting 175 
enhanced specificity for GABARAP family members. Interestingly, the interaction between FLCN and 176 
GABARAP in vivo in mammalian cells was not detectable unless FNIP1/2 was also present. FNIP2 177 
especially was able to potently enhance the interaction (Fig. 3D). The interaction in mammalian cells was 178 
clearly specific for GABARAP, and not LC3B. We further confirmed this stronger interaction of 179 
GABARAP to FLCN-FNIP1/2 by using in vitro binding assays with recombinant GABARAP protein 180 
(Fig. S2B). Immunofluorescence analysis revealed co-localisation of FLCN with GABARAP at punctate 181 
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structures when co-expressed with FNIP2 (Fig. 3E). Overall, these data reveal that FLCN/FNIP interacts 182 
with the autophagy machinery via GABARAP. 183 
 184 
FLCN does not function upstream of ULK1 – ULK1 is a key activator of the autophagy cascade and a 185 
known GABARAP interactor.
35
 We observed a weak interaction between V5-tagged ULK1 and HA-186 
FLCN (Fig. 4A), which suggests that FLCN might influence autophagy at the level of ULK1. This 187 
FLCN-ULK1 interaction was markedly enhanced when ULK1 contained a kinase inactivating mutation 188 
(K46I, referred to as kinase-dead). In a reciprocal experiment, immunoprecipitated HA-FLCN similarly 189 
showed a more robust interaction with kinase-dead ULK1 (Fig. S3A). 190 
 191 
To determine whether this observed FLCN-ULK1 interaction had a cellular function, we analysed 192 
whether ULK1 activity could be modulated by FLCN knockdown. To do this, we examined the 193 
comparative activity of both AMPK and mTORC1, as these signalling pathways are known to impact 194 
autophagy through ULK1 phosphorylation.
10-12, 15-17
 AMPK activates autophagy via phosphorylation of 195 
ULK1 at Ser555,
15
 while Ser758 phosphorylation of ULK1 by mTORC1 is inhibitory and appears to 196 
modulate ULK1-AMPK interaction.
16,17
 Both AMPK and mTORC1 have also been previously linked to 197 
FLCN.
27-29, 36
 In control HK2 cells, starvation potently induced the phosphorylation of ULK1 at the 198 
AMPK-mediated site (Ser555), while growth media induced the phosphorylation of the mTORC1 site 199 
(Ser758) (Fig. 4B). Importantly, we did not notice any marked differences in the levels of ULK1 200 
phosphorylation upon FLCN knockdown, except a modest elevation in ULK1 phosphorylation at Ser758 201 
under starvation conditions. Through ULK1 kinase assays, we further confirmed that endogenous ULK1 202 
activity was not significantly impacted upon loss of FLCN (Fig. 4C). 203 
 204 
ULK1 phosphorylates FLCN - Unlike wild-type ULK1, kinase dead ULK1 is predominantly found in a 205 
larger 1.2 MDa complex, suggesting that autophosphorylation as well as substrate phosphorylation is 206 
necessary for normal interaction dynamics between ULK1 and substrates.
37
 As wild-type ULK1 appears 207 
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to weakly interact with FLCN compared to kinase-dead ULK1 (Fig. 4A), this transient interaction might 208 
be modulated through ULK1 phosphorylation. To determine whether ULK1 phosphorylates FLCN, we 209 
[-32P]-orthophosphate radiolabelled HEK293 cells expressing HA-FLCN in vivo and determined [-32P]-210 
incorporation into HA-FLCN in the presence or absence of ULK1. We observed that ULK1 potently 211 
induced FLCN phosphorylation in vivo (Fig. 5A), implying that ULK1 might function upstream of FLCN. 212 
To test whether ULK1 directly phosphorylates FLCN, we performed in vitro ULK1 kinase assays towards 213 
FLCN and a known ULK1 substrate, ATG13.
10,11
 We found that wild-type ULK1 robustly 214 
phosphorylated both FLCN and ATG13 in vitro, whereas no phosphorylation was detected with kinase 215 
dead ULK1 (Fig. 5B). This data reveals that FLCN is directly phosphorylated by ULK1. Through mass 216 
spectrometry, we identified multiple ULK1-mediated phosphorylation events towards FLCN in cells. 217 
Within the C-terminus of FLCN, we observed three new phosphorylation sites (Ser406, Ser537 and 218 
Ser542), which were unique to FLCN when co-expressed with wild-type ULK1 but not kinase dead 219 
ULK1 (Fig. 5C and S3B-D). The Ser406 signal was not localised, but the closest alternative candidate 220 
phosphorylation site is Ser407, which is not as well conserved between species (Fig. 5C). The other two 221 
localised ULK1 sites, Ser537 and Ser542, are well conserved between species (Fig. 5C). Additional 222 
ULK1-mediated phosphorylation sites were observed in the linker region of FLCN (Ser316/Thr317), but 223 
these residues are poorly conserved amongst species (Fig. S3E). A structural model showing the three 224 
best conserved ULK1-mediated phosphorylation sites of FLCN was generated from the recently 225 
determined C-terminal crystal structure of FLCN (Fig. 4D).
38
 From the crystal structure [PDB Id: 3V42], 226 
we observed that all three ULK1 phosphorylation sites are solvent exposed to the surrounding 227 
environment, making them accessible for phosphorylation.  228 
 229 
ULK1 modulates the FLCN-GABARAP complex – To determine whether FLCN phosphorylation by 230 
ULK1 had a functional consequence, we analysed the FLCN-FNIP2-GABARAP complex in the presence 231 
of over-expressed ULK1. We found that expression of wild-type ULK1 impaired the interaction of 232 
GABARAP with FLCN/FNIP2, whereas this interaction remained intact in the presence of kinase dead 233 
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ULK1 (Fig. 6A). In agreement with the literature,
35
 ULK1 was also found in the GABARAP 234 
immunoprecipitates. In support of the finding that ULK1 modulates the FLCN-GABARAP interaction, 235 
knockdown of endogenous ULK1 expression by shRNA under normal growth conditions markedly 236 
strengthened the interaction between FLCN/FNIP2 and GABARAP (Fig. 6B). Collectively, this data 237 
implies that the kinase activity of ULK1 is required for FLCN/FNIP2 dissociation from GABARAP. To 238 
determine whether the three identified phosphorylation sites in FLCN were important for modulating the 239 
interaction, we tested the in vitro binding of both wild-type and a triple serine-to-alanine FLCN mutant 240 
(3A) to bacterially expressed GST-GABARAP or GST-LC3B as bait. Loss of these phosphorylation sites 241 
modestly enhanced binding of FLCN to GABARAP and LC3B (Fig. 6C). As observed previously (Fig. 242 
3C), FLCN preferentially bound to GABARAP. However, when we tested the strength of FLCN(3A)-243 
GABARAP binding in mammalian cells, we found that ULK1 expression could still cause disassembly of 244 
the complex (data not shown).  This suggests that additional ULK1-mediated phosphorylation events (i.e., 245 
additional sites within FLCN and/or FNIP2) further regulate formation of the FLCN-FNIP2-GABARAP 246 
complex in cells. However, we observed slight impairment in the ability of the FLCN(3A) mutant to drive 247 
autophagy in cells, as determined by a modest repression of SQSTM1 expression when compared to wild-248 
type FLCN (Fig. 6D). 249 
 250 
Patient tumours show autophagy defects – To determine whether our findings translated to clinical 251 
samples, we analysed SQSTM1 protein levels along with the ATG8 family members, GABARAP and 252 
LC3, in a BHD patient renal tumour containing two mutated copies of FLCN (a c.499C>T mutation 253 
(encoding a truncated FLCN mutant, pGln167X) in one allele and deletion of exon 6 in the other allele).
39
 254 
We found that SQSTM1 and GABARAP proteins were elevated in both chromophobe and clear cell 255 
sections of the tumour when compared to normal control kidney tissue, with slight elevation of LC3 (Fig. 256 
7A). The observation of raised LC3 and SQSTM1 protein levels could indicate a blockage in the 257 
autophagic pathway, preventing proper autophagic flux. We next determined whether FLCN mutants 258 
exhibited altered association with ULK1 and GABARAP. We tested ULK1 interaction with a panel of 259 
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BHD-patient derived mutations (curated in the Leiden Open Variation Database). We discovered that the 260 
C-terminal truncating mutations (Y463X and H429X) interacted more avidly with ULK1 than either wild-261 
type FLCN or a BHD patient-derived point mutation, K508R (Fig. 7B). This suggests that the extreme C-262 
terminus of FLCN does not bind directly to ULK1 and may play a role in dissociation from ULK1. In 263 
contrast, these truncation mutants of FLCN show impaired binding to GABARAP (Fig. 7C). 264 
Additionally, the mutants were not able to repress SQSTM1 levels as efficiently as wild-type FLCN (Fig. 265 
7D). Collectively, our data suggest that FLCN functions as a positive modulator of autophagy, where loss 266 
of FLCN impairs basal autophagy, both in vitro and in the disease setting. 267 
 268 
Discussion 269 
 270 
In this study, we discover that FLCN is a new ULK1 substrate, and FLCN phosphorylation by ULK1 271 
modulates the interaction of FLCN-FNIP2 with the autophagy component, GABARAP. Our analysis 272 
reveals that multiple residues within FLCN are phosphorylated in an ULK1-dependent manner. We also 273 
uncover that FLCN plays a positive role in autophagy, where loss of FLCN leads to impaired autophagic 274 
flux. 275 
 276 
The binding partners of FLCN, FNIP1 and FNIP2, have previously been connected to B-cell 277 
development,
40
 autophagy via GABARAP
34
 and the induction of apoptosis following DNA-base 278 
mispairing.
41
 We reveal that FNIP2 (and to a lesser extent FNIP1) enhances FLCN-GABARAP binding, 279 
implying that FLCN functions as a complex with FNIP proteins to regulate autophagy. Lack of this 280 
functional complex due to FLCN mutations in BHD syndrome could explain the impaired autophagy 281 
observed in tumour tissue from BHD syndrome patients. 282 
 283 
GABARAP subfamily members appear to function downstream of autophagosome membrane elongation 284 
in a step coupled to dissociation of the ATG12-ATG5-ATG16L complex
8
 and have been hypothesised to 285 
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recruit and anchor the ULK1 complex on autophagosomes.
35, 42
 ULK1, along with its binding partners, 286 
ATG13 and FIP200, contain LC3-interacting region (LIR) motifs which preferentially bind to the 287 
GABARAP subfamily of ATG8 proteins.
35, 42
 As FLCN appears to have a preference for binding 288 
GABARAP over LC3B, it is likely that FLCN modulates autophagy through GABARAP-dependent 289 
processes. Additionally, FNIP2 has a potential LIR motif (Fig. S4), while FNIP1 does not, which might 290 
explain why FNIP2 further enhances the FLCN-GABARAP interaction. 291 
 292 
We detected elevated SQSTM1 protein levels, as well as GABARAP and LC3, in BHD kidney tumours 293 
compared with normal kidney tissue. Interestingly, upregulation of SQSTM1 is observed in several 294 
cancers, including glioblastoma multiforme,
43
 colorectal cancer
44
 and hepatocellular carcinomas,
45
 while 295 
genomic amplification of the SQSTM1 gene is seen in some clear cell renal cell carcinomas.
31
 SQSTM1 is 296 
also overabundant in breast cancer,
46
 where its expression level correlates with poorer disease-free 297 
survival.
47
 Similarly, elevated SQSTM1 is associated with poor prognosis in lung cancer patients.
48
 It is 298 
known that genetic inactivation of Atg7 in mice leads to SQSTM1 accumulation and generation of 299 
ubiquitin-positive inclusions in the liver. This then sequentially leads to accumulation of nuclear Nrf2, 300 
enhanced cellular stress and hepatotoxicity.
49
 Sustained SQSTM1 expression has also been linked to 301 
tumorigenesis via elevated levels of reactive oxygen species and DNA damage
50
 in addition to enhanced 302 
cellular migration and invasion.
43
 A similar mechanism could operate in FLCN-deficient kidney cells, 303 
whereby inactivation of FLCN causes autophagy deficiencies and elevated SQSTM1 levels, and the 304 
resulting cellular stress could promote tumour development. 305 
 306 
Recently, both SQSTM1 and FLCN have been linked to amino acid sensing through the Rag proteins and 307 
mTORC1. SQSTM1 was found to bind the Rag proteins to favour formation of the active Rag 308 
heterodimer, thereby helping activate mTORC1 at the lysosome.
51
 Three publications have now linked the 309 
FLCN/FNIP complex to the Rags at the lysosome, linking FLCN to amino acid-dependent mTORC1 310 
signalling.
27-29
 We did not detect substantially altered mTORC1 signalling following FLCN loss in our 311 
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cell line model under normal or starved conditions, while other publications have found enhanced 312 
mTORC1 activity in animal models lacking FLCN, at least in certain cell types.
32, 52
 It appears that 313 
mTORC1 signalling in the context of FLCN-deficiency is cell type dependent and can also alter during 314 
tumour development in response to accumulation of other genetic mutations. 315 
 316 
BHD syndrome has lately been reported to be a ciliopathy,
25
 as alteration to FLCN levels can cause 317 
changes to the onset of ciliogenesis. Changes in FLCN levels are also associated with disruption of planar 318 
cell polarity and dysregulation of the canonical Wnt signalling pathway. As a compromised ability to 319 
activate the autophagic response may be an underlying feature in some ciliopathies,
26
 it is possible that 320 
there is also an association between cilia and autophagy in BHD syndrome. For instance, impaired 321 
autophagy could be a contributing factor to ciliary defects and renal cyst formation in BHD syndrome 322 
patients. 323 
 324 
While our work helps refine our understanding of FLCN by revealing that FLCN interacts with 325 
components integral to autophagy, it is important to highlight that FLCN function is not just restricted to 326 
autophagy or the lysosome. For instance, FLCN also interacts with p0071 (also known as plakophilin-4) 327 
involved in desmosomal and adherens junctions.
53, 54
 Additionally, multiple pathways that drive cancer 328 
progression can become dysregulated when FLCN expression is lost, including defects in TGF-mediated 329 
signalling,
55,56
 enhanced hypoxia inducible factor activity
57
 and TFE3 activity.
58
 Therefore, FLCN appears 330 
to play a broader ‘housekeeping’ role in the cell and is likely to be a fundamental player in autophagy and 331 
cellular homeostasis outside the disease setting. Although further studies are required, it seems reasonable 332 
to assume that impaired autophagy upon loss of FLCN expression contributes in part to cancer 333 
progression in BHD patients. 334 
 335 
 336 
 337 
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Materials and Methods 338 
Cell Culture - Stable FLCN knockdown in HK2 cells was previously described.
25
 Flcn+/+ and -/- MEF 339 
cells were gifted by Prof. Arnim Pause (McGill University, Canada) derived from mice described 340 
previously.
32
 All cell lines were cultured in DMEM supplemented with 10 % (v/v) foetal calf serum, 100 341 
U/ml penicillin and 100 μg/ml streptomycin (Life Technologies). Lipofectamine 2000 transfection was 342 
used unless otherwise stated and performed according to the manufacturer’s protocol (Life Technologies). 343 
Cells were harvested 24–36 h post-transfection. Experiments were performed under normal growth 344 
conditions, unless otherwise stated. For complete starvation, cells were washed twice in phosphate 345 
buffered saline (PBS) and incubated in Krebs Ringer buffer (KRB) (20 mM HEPES (pH 7.4), 115 mM 346 
NaCl, 5 mM KCl, 10 mM NaHCO3, 2.5 mM MgCl2, 2.5 mM CaCl2) for 4 h.  347 
 348 
Plasmids - V5-ULK1 wild-type and kinase dead (K46I) and GST-ATG13 have been described 349 
previously.
22
 HA-FLCN was generated in the pN3HA backbone (a kind gift from Dr. Sylvia Neumann, 350 
The Scripps Research Institute, San Diego, USA) and untagged-FLCN in the pcDNA3.1 vector. GST-351 
FLCN in pDEST27 and V5-FNIP1 in pcDNA3.1/nV5-DEST were generated using the Gateway system 352 
(Life Technologies). HA-FNIP1 was a kind gift from Dr. Laura Schmidt (National Institutes of Health, 353 
Bethesda, USA) and myc-FNIP2 was a kind gift from Dr. O. Hino (Juntendo University School of 354 
Medicine, Tokyo, Japan).
59
 HA-SQSTM1 (Plasmid #28027)
60
 and ptfLC3 vector (Plasmid #21074)
33
 355 
were from Addgene. LC3B and GABARAP (from pDONR
34
) were cloned into pDEST15 (Life 356 
Technologies) or pcDNA-HA, respectively. Mutations were introduced using the QuikChange Site-357 
directed mutagenesis kit (Stratagene, Agilent Technologies). 358 
 359 
Antibodies - Anti-HA antibody (11867423001) was purchased from Roche. Anti--actin (4967), phospho-360 
ULK1 Ser555 (5869) and Ser758 (6888) and total ULK1 (4773) antibodies were from Cell Signaling. 361 
Anti-V5 (46-0705) was from Life Technologies. Anti-Myc clone 9E10 antibody (M5546) was from 362 
Sigma-Aldrich and anti-GST antibody (05-782) was from Merck Millipore. Anti-FLCN was gifted from 363 
FLCN is a novel regulator of autophagy 
 
15 
Prof. Arnim Pause (McGill University, Canada). Anti-SQSTM1 (p62) C-terminal antibody (GP62-C/DS-364 
160211) was from Progen Biotechnik GmbH. Anti-LC3 antibody for immunofluorescence and 365 
immunohistochemistry was from Novus Biologicals (NB100-2220), for western blotting from Nanotools 366 
(0260-100/LC3-2G6). GABARAP antibody (AP1821a) was from Abgent. 367 
 368 
shRNA knockdown - JetPEI transfection mixtures containing 2 g of scrambled shRNA or ULK1 shRNA 369 
(MISSION shRNA 1-1064slcl, Sigma) were prepared according to the manufacturer’s protocol (Polyplus-370 
transfection) and reverse transfected into HEK293 cells. Following incubation at 37 °C for 24 h, plates 371 
were then transfected with V5-FLCN, myc-FNIP2 and HA-GABARAP using the JetPEI protocol 372 
(forward transfection) and incubated for a further 28 h prior to lysis. 373 
 374 
Immunoprecipitation, GST-pulldown and western blotting - Cells were lysed in BHD lysis buffer (20 mM 375 
Tris, 135 mM NaCl, 5 % (v/v) glycerol, 50 mM NaF and 0.1 % (v/v) Triton X-100, pH 7.5 plus protease 376 
inhibitors), centrifuged and protein quantified using Bradford reagent (Sigma-Aldrich).  Anti-HA and 377 
anti-V5 coupled to Protein G-Sepharose beads (GE Healthcare Life Sciences) were used to 378 
immunoprecipitate HA and V5-tagged proteins as appropriate. Immunoprecipitates were washed three 379 
times in lysis buffer and resuspended in NuPAGE LDS sample buffer (Life Technologies). Samples for 380 
GST-pulldown were lysed in Buffer B (40 mM HEPES (pH 7.5), 120 mM NaCl, 1 mM EDTA, 10 mM 381 
pyrophosphate, 10 mM β-glycerophosphate, 50 mM NaF, 1.5 mM Na3VO4, 0.3% (w/v) CHAPS plus 382 
protease inhibitors) and incubated with glutathione-Sepharose beads (GE Healthcare Life Sciences). 383 
Beads were washed three times in lysis buffer, and GST-tagged proteins were eluted using 10 mM 384 
glutathione. Western blotting was performed as previously described.
22
 Blots shown are representative of 385 
at least three independent experiments. 386 
 387 
ULK1 kinase assay - Cell lysates from nutrient-replete or starved HK2 cells were immunoprecipitated 388 
using anti-ULK1 antibody (J.T. Murray, Queen’s University, Belfast, UK). Immunocomplexes were 389 
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captured using protein G-Sepharose (GE Healthcare Life Sciences), washed three times in Low Salt 390 
Buffer (50 mM Tris-Cl (pH 7.5), 1 mM EGTA, 1 mM EDTA, 0.3 % (w/v) CHAPs, 1 mM sodium 391 
orthovanadate, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 0.27 M sucrose, 0.1 % (v/v) 2-392 
mercaptoethanol) and twice in Assay Buffer (20 mM HEPES (pH 7.5), 150 mM NaCl, 0.1 % -393 
mercaptoethanol, 25 mM -glycerophosphate, 100 M orthovanadate). In vitro ULK1 kinase assays 394 
against GST-FLCN and GST-ATG13 (purified from HEK293 cells), were carried out using 395 
immunoprecipitated V5-tagged ULK1. The assay mix of immunoprecipitated ULK1, 10 mM MgAc, 396 
substrate (3 g MBP, GST-FLCN or GST-ATG13 as required) and 100 M [32P] ATP in Assay Buffer 397 
was incubated at 30 °C for 10 min, then quenched with sample buffer (Life Technologies) and subjected 398 
to SDS-PAGE. Relative levels of [
32
P]-incorporation were determined by autoradiography. 399 
 400 
Immunofluorescence and image analysis - HK2 cells were transfected with RFP-GFP-LC3 for 24 h, fixed 401 
with paraformaldehyde and imaged under oil immersion at 20°C using a Leica TCS SPE confocal laser 402 
scanning ﬂuorescence microscope, using Leica software (Leica DMRBE). Confocal images were stacked 403 
and merged using ImageJ v1.43 software. Puncta were counted manually across multiple fields of view 404 
from >10 cells per condition, over three independent experiments. The proportion of each type of puncta 405 
was calculated and plotted. For co-localisation experiments, MDCK cells were transfected with pEGFP-406 
FLCN-WT, myc-FNIP2 and HA-GABARAP using MetaFectene Pro. After 46 h, cells were washed twice 407 
in PBS and starved in KRB containing 4.5 g/l glucose. Cells were stained with mouse-anti-HA (Cell 408 
Signaling, 2367) and polyclonal FNIP2 antibody directed against AA117-131 of human FNIP2. 409 
Secondary antibodies were goat-anti-rabbit-Alexa568 (Life Technologies, A11036) and goat-anti-mouse-410 
Cy5 (Southern Biotech, 1034-15), with DAPI counterstain. 411 
 412 
Binding of FLCN to GST-baits - Bacterially expressed GST, GST-LC3B and GST-GABARAP were 413 
purified using glutathione beads, washed in BHD lysis buffer and then incubated with lysate from 414 
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HEK293 cells transfected with HA-FLCN (WT or 3A), HA-FNIP1 or myc-FNIP2. Beads were washed 415 
three times in lysis buffer, and GST-tagged proteins eluted using 10 mM glutathione. 416 
 417 
In vivo radiolabelling - Transfected HEK293 cells were incubated in phosphate-free medium containing 418 
0.2 mCi [
32
P]-orthophosphate (PerkinElmer) for 4 h. These cells were harvested using BHD lysis buffer. 419 
HA-FLCN was immunoprecipitated with anti-HA antibody bound to protein G-Dynabeads (Life 420 
Technologies) and washed in lysis buffer. 421 
 422 
Mass spectrometry - GST-FLCN was purified from HEK293 cells co-expressing wild-type or kinase dead 423 
ULK1. Samples were separated by SDS-PAGE and excised bands were subjected to a modified in-gel 424 
trypsin digestion procedure.
61
 Eluted peptides were subjected to electrospray ionization prior to LTQ-425 
Orbitrap mass spectrometry (Thermo Fisher). Peptide sequences were determined by matching protein or 426 
translated nucleotide databases with the acquired fragmentation pattern by Sequest (ThermoFinnigan).
62
 427 
Modification of 79.9663 mass units to serine, threonine and tyrosine was included in the database 428 
searches to determine phosphopeptides and manually inspected to ensure confidence. 429 
 430 
Structural modelling - Crystal structure coordinates used in the current manuscript are as deposited in the 431 
protein data bank
38
 (PDB Id: 3V42). The model was generated using Pymol.  432 
 433 
Immunostaining of patient tumour - Tissue sections were processed using standard methodology.
25
 434 
Sections were incubated with antibodies for LC3, GABARAP and p62/SQSTM1 antibody (610832, BD 435 
Bioscience) in 3% (w/v) bovine serum albumin overnight at 4 °C. 436 
 437 
GABARAP Interaction network - GABARAP interaction mass spectrometry was performed and analysed 438 
as described previously,
34
 with the exception that autophagy interaction network baits (33 thereof) were 439 
stably expressed using the MSCV NTAP system in A549 non-small cell lung carcinoma cell lines. 440 
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 441 
Densitometry and statistical analysis - Densitometry was performed using ImageJ v1.43 software. 442 
Student’s t-test or one way ANOVA followed by LSD post-hoc testing (as appropriate) were used for 443 
statistical analysis, with p < 0.05 taken to be significant. 444 
 445 
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Figure Legends 641 
 642 
Figure 1: SQSTM1 levels are elevated in FLCN-deficient cells and BHD-tumour derived tissue 643 
(A) Control HK2 cells (non-target (NT) shRNA) and those with stable knockdown of FLCN were starved 644 
for 4 h in Kreb’s Ringer Buffer (KRB) or grown in normal media and SQSTM1 levels were analysed. 645 
Data is mean ± S.E.M of 3 independent experiments. (B) HA-FLCN was re-expressed (with co-expressed 646 
HA-SQSTM1) in FLCN knockdown HK2 cells and HA-SQSTM1 levels were analysed by western blot. 647 
Data is mean ± S.E.M of 3 independent experiments. *** p < 0.001. (C) A tumour sample (T) showing 648 
mixed histology of clear and chromophobe cells, and surrounding normal tissue (N) from a BHD patient 649 
was stained for SQSTM1. The scale bar is 100 m. 650 
 651 
Figure 2: FLCN is a positive driver of autophagy 652 
 (A) HK2 control and FLCN knockdown cells were transfected with the ptfLC3 vector, fixed and 653 
examined by confocal microscopy. Representative maximal Z‑projection images of cells showing the 654 
RFP-GFP-LC3 puncta are shown. Scale bar is 10 m. Red and yellow puncta were scored across three 655 
independent experiments (at least 30 cells per cell line in total) and are plotted in (B) mean ± S.E.M. (C) 656 
Control HK2 cells and those with stable knockdown of FLCN were treated with 100 M chloroquine 657 
(CQ) for the indicated times. Samples were probed for conversion of LC3B (graphed in panel below, 658 
mean ± S.E.M.) and GABARAP expression. (D) As for (C) but in HEK293 cells with transient 659 
knockdown of FLCN expression. For all graphs * p < 0.05, ** p < 0.01. 660 
 661 
Figure 3: FLCN interacts with GABARAP, which is enhanced in the presence of FNIP1/2 662 
(A) A network of GABARAP interactors, as determined by mass spectrometry. (B) GST alone or GST-663 
GABARAP was used as bait, and bound endogenous FLCN was detected by western blot. (C) Bacterially 664 
expressed GST, GST-LC3B and GST-GABARAP was used as bait for lysates with or without over-665 
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expression of HA-FLCN. Following GST purification, bound HA-FLCN was detected by western blot. 666 
(D) V5-FLCN, HA-LC3B or HA-GABARAP were expressed in HEK293 cells with FNIP proteins where 667 
indicated. Following an HA immunoprecipitation, V5-FLCN was detected by western blot. Total blots 668 
represent 30 % of IP input. (E) MDCK cells were transfected with EGFP-FLCN-WT, myc-FNIP2 and 669 
HA-GABARAP. Cells were stained with mouse-anti-HA and polyclonal FNIP2 antibody. Scale bar is 20 670 
m. 671 
 672 
Figure 4: FLCN interacts with ULK1 but does not alter ULK1 activity 673 
(A) FLCN was co-expressed with V5-tagged wild-type (WT) or kinase dead (KD) ULK1 as indicated in 674 
HEK293 cells, and subjected to V5 immunoprecipitation. FLCN bound to ULK1 was detected by western 675 
blotting. Total blots represent 40 % of IP input. (B) Control HK2 cells and those with stable knockdown 676 
of FLCN were transfected with kinase dead ULK1 for 24 h, followed by starvation for 4 h in KRB where 677 
indicated. V5-tagged ULK1 was immunoprecipitated and probed for phosphorylation at Ser555 and 678 
Ser758. (C)  Endogenous ULK1 activity was measured by incorporation of [
32
P] into myelin basic protein 679 
(MBP). The graph shows relative ULK1 activity across three independent experiments, mean ± S.E.M. 680 
NS = not significant, * p < 0.05. 681 
 682 
Figure 5: ULK1 phosphorylates FLCN 683 
(A) Incorporation of [
32
P] into HA-FLCN in vivo was determined in the presence and absence of ULK1. 684 
(B) Both ATG13 and FLCN can be phosphorylated by wild-type (WT) but not kinase dead (KD) ULK1 685 
in vitro. (C) A multi-species alignment of FLCN proteins using Clustal Omega shows that the Ser406, 686 
Ser537 and Ser542 phosphorylation sites are well conserved between species. (D) Cartoon representation 687 
of the mapped phosphorylation sites on the crystal structure of the FLCN C-terminal domain (PDB Id: 688 
3V42). The insets show a closer view of the serine residues, which are represented as sticks. 689 
 690 
 691 
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Figure 6: ULK1 modulates the FLCN-GABARAP interaction 692 
(A) V5-FLCN and myc-FNIP2 bound to HA-GABARAP in the presence or absence of wild-type (WT) or 693 
kinase dead (KD) V5-ULK1 were determined by immunoprecipitating HA-GABARAP and detecting 694 
bound proteins by western blot. Total blots represent 20% of IP input. (B) Cells were transfected with 695 
control or ULK1 shRNA, along with V5-FLCN, myc-FNIP2 and HA-GABARAP and grown in complete 696 
DMEM. Following an HA immunoprecipitation, V5-FLCN and myc-FNIP2 were detected by western 697 
blot. Total blots represent 20 % of IP input. The graphs show relative binding of V5-FLCN to HA-698 
GABARAP and myc-FNIP2 to HA-GABARAP as determined by densitometry across four independent 699 
experiments, mean ± S.E.M.  * p < 0.05. (C) Bacterially expressed GST, GST-LC3B or GST-GABARAP 700 
was used as bait for lysates containing HA-FLCN (WT or 3A mutant). Following GST purification, 701 
bound HA-FLCN was detected by western blot (right panel). GST loading controls are shown in the left-702 
hand panel. (D) Wild-type (WT) FLCN, or the serine-to-alanine (3A) FLCN mutant, were re-expressed in 703 
FLCN-deficient HK2 cells, along with HA-SQSTM1. HA-SQSTM1 levels were determined by western 704 
blot and densitometry of SQSTM1 levels from three independent experiments are plotted in the graph, 705 
mean ± S.E.M.  * p < 0.05, *** p < 0.001. 706 
 707 
Figure 7: Patient tumours and patient-derived FLCN mutations show autophagy defects 708 
(A) Kidney tumour tissues from a BHD patient showing mixed histology of clear cell and chromophobe 709 
cells, were stained for SQSTM1, GABARAP and LC3 and compared to normal kidney. The scale bar is 710 
50 m. (B) HA-FLCN (wild-type or patient-derived mutants) was co-expressed with V5-tagged wild-type 711 
(WT) ULK1 in HEK293 cells, and subjected to V5 immunoprecipitation. FLCN bound to ULK1 was 712 
detected by western blotting. Total blots represent 40 % of IP input. (C) HA-GABARAP was co-713 
expressed with untagged-FLCN (wild-type or patient-derived mutants) and myc-FNIP2 in HEK293 cells, 714 
and subjected to HA immunoprecipitation. FLCN bound to GABARAP was detected by western blotting. 715 
Total blots represent 5 % of IP input. (D) Untagged FLCN (wild-type or mutants) was re-expressed (with 716 
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co-expressed HA-SQSTM1) in FLCN knockdown HK2 cells and HA-SQSTM1 levels were analysed by 717 
western blot. Data is mean ± S.E.M of 5 independent experiments. * p < 0.05, ** p < 0.01. 718 
 719 
Supplementary Figure Legends 720 
 721 
Fig. S1: Autophagy is impaired in Flcn-deficient MEF cells 722 
(A) FLCN-expressing or deficient MEF cells were given normal growth media or starved in KRB for 4 h. 723 
Total cell lysates were analysed for SQSTM1 levels by western blotting. Relative levels were determined 724 
by densitometry and are plotted as mean ± S.E.M. for three independent experiments. * p < 0.05 (B) 725 
GABARAP mRNA expression levels in HK2 cells expressing and deficient for FLCN were determined by 726 
Q-PCR. 727 
 728 
Fig. S2: The FLCN/FNIP complex binds to GABARAP 729 
(A) The peptide sequence of the longest isoform of human FLCN is shown. Highlighted are the peptides 730 
identified in two technical replicate LC-MS/MS analyses of NTAP-GABARAP immunoprecipitates (first 731 
replicate is bold, second replicate is underlined). (B) Bacterially expressed GST-GABARAP was used as 732 
bait for lysates containing HA-FLCN with or without FNIP1 or FNIP2, where indicated. Following GST 733 
purification, bound HA-FLCN was detected by western blot.  734 
 735 
Fig. S3:  Mass spectrometry reveals three ULK1-mediated phosphorylation sites on FLCN 736 
(A) HA-FLCN was co-expressed with V5-tagged wild-type (WT) or kinase dead (KD) ULK1 as indicated 737 
in HEK293 cells, and subjected to HA immunoprecipitation. ULK1 bound to FLCN was detected by 738 
western blotting. (B-D) Mass spectrometry (LC-MS/MS) was used to determine the phosphorylated 739 
residues of FLCN co-expressed with ULK1. (E) A multi-species alignment of FLCN proteins using 740 
Clustal Omega shows that the potential ULK1-mediated phosphorylation sites, Ser316 and Thr317 are not 741 
well conserved. 742 
FLCN is a novel regulator of autophagy 
 
30 
 743 
Fig. S4:  FNIP2 contains a potential LIR motif 744 
The canonical LIR motif together with a sequence comparison of LIR motifs identified in ULK1, ATG13 745 
and FIP200, as well as a potential LIR motif within FNIP2.  746 
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Fig. S1: Autophagy is impaired in Flcn-deficient MEF cells
(A) FLCN-expressing or deficient MEF cells were given normal growth media or starved in KRB 
for 4 h. Total cell lysates were analysed for SQSTM1 levels by western blotting. Relative levels 
were determined by densitometry and are plotted as mean ± S.E.M. for three independent 
experiments. * p < 0.05 (B) GABARAP mRNA expression levels in HK2 cells expressing and 
deficient for FLCN were determined by Q-PCR.
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Fig. S2: The FLCN/FNIP complex binds to GABARAP
(A) The peptide sequence of the longest isoform of human FLCN is shown. Highlighted are the 
peptides identified in two technical replicate LC-MS/MS analyses of NTAP-GABARAP 
immunoprecipitates (first replicate is bold, second replicate is underlined). (B) Bacterially 
expressed GST-GABARAP was used as bait for lysates containing HA-FLCN with or without FNIP1 
or FNIP2, where indicated. Following GST purification, bound HA-FLCN was detected by western 
blot. 
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Fig. S3:  Mass spectrometry reveals three ULK1-mediated phosphorylation sites on FLCN
(A) HA-FLCN was co-expressed with V5-tagged wild-type (WT) or kinase dead (KD) ULK1 as 
indicated in HEK293 cells, and subjected to HA immunoprecipitation. ULK1 bound to FLCN 
was detected by western blotting. (B-D) Mass spectrometry (LC-MS/MS) was used to 
determine the phosphorylated residues of FLCN co-expressed with ULK1. (E) A multi-species 
alignment of FLCN proteins using Clustal Omega shows that the potential ULK1-mediated 
phosphorylation sites, Ser316 and Thr317 are not well conserved.
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Fig. S4:  FNIP2 contains a potential LIR motif
The canonical LIR motif together with a sequence comparison of LIR motifs identified in ULK1, 
ATG13 and FIP200, as well as a potential LIR motif within FNIP2. 
